Hematopoietic SH2 Domain Containing (HSH2D) (C-Term) Peptide
HSH2D
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all HSH2D products
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RSVSCIEVTP GDRSWHQMVV RALSSQESKP EHQGLAEPEN DQLPEEYQQP
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-HSH2D Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
- Background
-
T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 in naive T cells. HSH2 is a target of both of these signaling pathways.
Alias Symbols: ALX, FLJ14886, HSH2
Protein Interaction Partner: FES,TNK2,FES,TNK2
Protein Size: 352 - Molecular Weight
- 39 kDa
- Gene ID
- 84941
- NCBI Accession
- NM_032855, NP_116244
- UniProt
- Q96JZ2
-
You are here:
